Objectives-Preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism facilitates targeted surgery. We assessed the sensitivity of 3-dimensional (3D) sonography for preoperative localization of abnormal parathyroid glands.
4 parathyroid glands to identify and remove the abnormal gland. With the development of accurate imaging modalities and rapid intraoperative parathyroid hormone monitoring, surgeons are able conduct a more targeted operation. Minimally invasive parathyroidectomy has an improved cure rate, decreased hospital length of stay, and lower total hospital charge, without an increased rate of recurrent hypercalcemia. 7, 8 Imaging modalities for preoperative localization of abnormal parathyroid glands include sonography, sestamibi scans, computed tomography (CT), and magnetic resonance imaging (MRI). Historically, the reported sensitivity of 2-dimensional (2D) sonography for identifying an abnormal parathyroid gland has ranged from 57% to 89%. [9] [10] [11] [12] [13] [14] [15] [16] Sensitivities of sestamibi scans in combination with single-photon emission CT have been reported to be between 88% and 96%. [17] [18] [19] [20] [21] Combining sestamibi scans and 2D sonography yielded increased sensitivity of 96% when the same gland was localized. 14, 22 Computed tomography and MRI have been reserved for localizing glands in patients undergoing reoperation. [23] [24] [25] Three-dimensional (3D) sonography has been shown to be useful in obstetrics, gynecology, and thyroid imaging. [26] [27] [28] [29] [30] It allows postprocessing reconstruction of the images in all planes, including the coronal view, which is most similar to that of the surgical field of a parathyroidectomy. In addition, it enhances visualization of specific vascular characteristics typical for enlarged parathyroid glands. 31, 32 Therefore, 3D sonography has the potential to facilitate preoperative localization of abnormal parathyroid glands. In this article, we report the sensitivity of 3D sonography in identifying abnormal parathyroid glands in patients with hyperparathyroidism before parathyroidectomy.
Materials and Methods
After approval from our Institutional Review Board, we conducted a retrospective review of 52 patients who underwent their first exploration for hyperparathyroidism from January 2010 through April 2015 and had imaging studies at a single outpatient imaging center at Montefiore Medical Arts Pavilion. No patients had familial hyperparathyroidism. No reoperative parathyroid cases were included. We searched for patients using Clinical Looking Glass software (Emerging Health IT, Yonkers, NY). We used Clinical Looking Glass to identify neck 2D sonograms, 3D sonograms, and sestamibi scans obtained before the date of surgery. We used a radiology information system (GE Healthcare, Milwaukee, WI) and Montage (Montage Healthcare Solutions, Inc, Burlington, MA) to ensure that all patients who underwent 3D sonography were included.
All of the patients underwent 2D and 3D sonography and sestamibi scanning. The original preoperative localization of abnormal parathyroid glands in the patients included in this study had been determined on the basis of the clinical results of the 2D and 3D sonographic examinations and the sestamibi scans. Twodimensional sonograms were obtained in sagittal and transverse planes with an ML6-15-D small-parts/pediatric linear transducer (frequency, 6-15 MHz). Cine sweeps were recorded when they were obtained. All of the 2D static images and cine sweeps were reviewed. A physician overscan was occasionally required. Evaluation of the 2D sonograms required an average of 10 minutes.
The 3D sonograms were obtained with a LOGIQ 9 3D ultrasound system (GE Healthcare) and an RSP6-16-D small-parts/pediatric linear transducer (frequency, 6-15 MHz). Two 3D sonographic data volumes were acquired for each suspected abnormal parathyroid, 1 with grayscale and 1 with color Doppler imaging. ViewPoint software was used for reconstruction. Generally, multiplanar reconstruction, surface rendering, and tomographic ultrasound imaging techniques were used. Although the data sweeps were obtained with breath holding and without swallowing, some patients had difficulty with these restrictions. To address this issue, the volume of the sweep was diminished, and the shorter scan time improved the results. Evaluation of the 3D sonograms required a maximum of 20 minutes, which included creating the reconstruction as well as analysis.
Sestamibi scans were conducted with 20 mCi of technetium Tc 99m sestamibi injected intravenously, with planar wide and zoom images of the patient's neck and chest obtained at multiple time points after injection out to 2 hours. Single-photon emission CT and CT with coronal, sagittal, and axial reconstructions were also performed during sestamibi imaging. Afterward, 10 mCi of technetium Tc 99m pertechnetate was injected intravenously, and 15 minutes later, planar images of the neck and upper chest were again obtained.
The final localization of the parathyroid gland was determined by the surgical report. We also reviewed surgical reports to determine the length of surgery and the need for bilateral exploration. Abnormal glands were confirmed by a 50% decrease in intraoperative parathyroid hormone after gland removal and were diagnosed as parathyroid adenoma or hyperplasia on pathologic examinations. 33 The abnormal parathyroid gland weight was obtained from the pathologic report. All patients had normal calcium and parathormone levels at 6 months.
For this study, 2 radiologists independently retrospectively reviewed the 3D and 2D sonograms. To assess for inter-reader variability, the image sets were reviewed independently, and the readers were blinded to the clinical results, including pathologic, surgical, and sestamibi results. The retrospective review occurred after a "wash-out" period of 1 year or more after the original clinical interpretations. Both readers were provided with the same retrospective 2D and 3D sonographic cases, which they interpreted independently without knowledge of the clinical results. Neither of the reviewers had the benefit of a check out with the sonographer or the ability to perform an overscan. The 3D sonograms were reviewed without knowledge of the results of the 2D sonographic examinations. The case order was not randomized because the times that the 2D and 3D sonograms were reviewed were separated by more than 1 month.
We calculated the overall sensitivities on a patient level for each radiologist separately, similar to methods identified in the literature. 22 The imaging results were considered true positive when the abnormal parathyroid glands were identified surgically on the same side as with imaging. The results were considered false negative when abnormal parathyroid glands excised surgically that were not identified by the imaging study. The results were considered false positive when the imaging identified an abnormal gland at an additional site from the abnormal gland(s) at surgery. Sensitivity was defined as true positive/(true positive 1 false negative). Dichotomous demographic and sensitivity variables were compared by the Fisher exact test. The McNamara test was used to compare dependent sensitivities. The j statistic and the associated bias-corrected 95% bootstrap confidence interval (CI) were calculated to assess case-bycase inter-reader agreement. Data were managed in Excel (Microsoft Corporation, Redmond, WA), and statistical analysis was conducted with Stata version 12.1 (StataCorp, College Station, TX). Graphs were made with GraphPad Prism version 6.0 (GraphPad Software, San Diego, CA). Two-tailed P < .05 was used as the criterion for statistical significance.
Results
The characteristics of the patients who underwent 2D and 3D sonography are summarized in Table 1 . To assess the relative abilities of 3D and 2D sonography in the identification of abnormal parathyroid glands, we compared the preoperative imaging results of each modality with the final surgical localization. We found 3D sonography to have sensitivity of 92% compared with 69% to 71% for 2D sonography (P < .001; Figure 1) . Sestamibi had sensitivity of 90%. Among patients in whom sonography and sestamibi localized the same abnormal parathyroid gland, the sensitivity was 100% (43 of 43) for 3D sonography.
The initial reader had sensitivities for 3D and 2D sonography of 92% and 69%, respectively (P 5 .001), and the other reader had sensitivities of 84% and 71% for 3D and 2D sonography (P 5 .005). According to the McNamara test, there was no significant difference between the readers' sensitivities for 3D sonography (P 5 .317). The increased sensitivity of 3D sonography compared with 2D sonography was particularly significant among glands smaller than 500 mg: 88% (21 of 24) versus 58% (14 of 24; P 5 .012). With glands larger than 500 mg, the difference in sensitivity between 3D and 2D sonography was 96% (24 of 25) compared with 84% (21 of 25; P 5 .083). Additionally, 3D sonography had significantly better inter-reader case-by-case concordance, with a j of 0.65 (95% CI, 0.55-0.83), which corresponded to substantial agreement, than 2D Frank et al-Sensitivity of 3D Sonography in Diagnosis of Abnormal Parathyroid Glands sonography, with a j of 0.41 (95% CI, 0.22-0.52), which corresponded to moderate agreement. 34 
Discussion
There are 2 pairs of parathyroid glands: the upper pair, deep to the medial mid thyroid gland, and the lower pair, deep and inferior to the lower pole of the thyroid. Primary hyperparathyroidism is usually caused by a single parathyroid adenoma. Until recently, 4-gland exploration was the standard of care. 35 Minimally invasive surgical techniques can reduce morbidity, depending on the accurate localization of the affected gland. 32, 36 Historically, preoperative sestamibi scanning was used to evaluate patients with suspected primary hyperparathyroidism. The addition of 2D sonography appeared to improve the diagnostic localization. 37 Four-dimensional CT is a newer imaging technique that has been suggested as more sensitive for parathyroid gland localization. It uses multiphase CT imaging to localize an abnormal parathyroid gland. 38 In a study from 2012, parathyroid adenomas were accurately lateralized by this technique in 93% of the cases. 38 In a more recent study, the sensitivity for localizing single-gland disease was 94%. 39 However, 4-dimensional CT exposes patients to radiation, even if dose-reducing techniques are used. 38 In addition, an iodinated contrast agent is necessary for this imaging technique. Furthermore, almost 25% of the lesions in one study did not have characteristic arterial enhancement and venous wash-out patterns and were, therefore, difficult to diagnose accurately. 39 On 2D sonography, the grayscale appearance of an enlarged parathyroid is of a hypoechoic or heterogeneous nodule with well-defined margins, measuring greater than 0.9 cm in any dimension (Figure 2) . 32 Two-dimensional grayscale and color Doppler sonograms of an abnormal gland show a wellcircumscribed hypoechoic nodule with an extrathyroidal feeding vessel and peripheral vascularity ( Figure  3 ). On color Doppler imaging, the vascular hallmarks of abnormal parathyroid glands are peripheral vascularity and a feeding vessel emanating from the carotid artery (Figures 4 and 5) . Three-dimensional sonography enhances the sensitivity for viewing this typical vascularity of abnormal parathyroid glands. Source 3D images can be reconstructed into a coronal view, which is particularly helpful for surgical planning, as it most resembles the surgical field seen by the surgeon ( Figure 4A) . 31, 32 Surface-and volume-rendered 3D views allow for visualization of the vascularity throughout the scan and show the feeding vessel of the abnormal parathyroid gland (Figure 4, A and B) . On tomographic ultrasound imaging, the data volume can be represented as consecutive slices, similar to CT or MRI ( Figure 5) . Visualization of the typical vascularity seen in an abnormal parathyroid gland is enhanced with 3D sonography.
In our study, we assessed the diagnostic accuracy of 3D sonography compared with 2D sonography for preoperative parathyroid localization in patients who underwent surgery for primary hyperparathyroidism. We found that 3D sonography was significantly more sensitive than 2D sonography for identifying abnormal parathyroid glands (89-92% versus 69-71%; P < .001). Three-dimensional sonography was particularly more sensitive than 2D sonography among smaller parathyroid glands measuring less than 500 mg (88% versus 58%; P 5 .012) in scans conducted on the same patients. When evaluated by 2 radiologists, 3D and 2D sonography had similar concordance on a case-by-case basis between the readers, with greater inter-reader concordance for 3D sonography (j 5 0.65) than 2D sonography (j 5 0.41). Taken together, these data demonstrate the increased sensitivity of 3D sonography compared with 2D sonography, particularly in smaller glands, as well as better inter-reader agreement. We had no case in which 3D sonography failed to identify parathyroid abnormalities that were seen on 2D sonography. We did have 1 ectopic parathyroid gland, which neither 2D sonography, 3D sonography, nor sestamibi localized before surgery. When combined with sestamibi scans, 2D sonography has been shown to have increased sensitivity compared with either 2D sonography alone or sestamibi scans alone.
14 Among patients who had 2D sonography and sestamibi scans that localized the abnormal gland to the same site, the diagnostic sensitivity has been reported as 96%. 22 In our study, the sensitivities for concordance of sonography with sestamibi scans were 100% for 3D sonography and 96% for 2D sonography. Due to the smaller sample size in our study, however, we could not determine the statistical significance.
To assess the generalizability of 3D sonographic interpretation, 2 radiologists independently interpreted 3D and 2D sonograms obtained from the same patients. Both radiologists had similar sensitivities for 3D and 2D sonography; 3D sonography showed better case-by-case concordance between the readers. Although not statistically significant, reader 2 had slightly lower sensitivity than reader 1 (84% versus 92%; P 5 .317), which may have been due to the greater experience of reader 1 with 3D sonography. In general, inter-reader agreement for parathyroid 2D sonography reported in the literature is poor, with j values as low as 0.35. 40 The increased conspicuity of the abnormal gland vascularity on 3D sonography after data set manipulation likely enhances reader confidence in identifying the abnormal glands.
The relatively low volume of surgery from our single outpatient imaging center limited our study. As all 3D sonographic examinations were conducted at a single imaging center at our institution, we do not know whether the improved sensitivity of 3D sonography can be generalized or was particular to that center. A larger study would be helpful, in addition, to assess the value of combined 3D sonography and sestamibi scans. The sonographer may have been inherently biased when performing the 3D examination after completing the 2D study and having come to a conclusion as to the likely location of the abnormal parathyroid gland(s). To address this factor, a future study could be performed in which 3D sonography is performed for the initial survey of the neck, without a prior 2D sonographic examination.
In conclusion, we demonstrate that targeted 3D sonography adds sensitivity to 2D sonography for preoperative identification of abnormal parathyroid glands in patients with primary hyperparathyroidism, particularly among smaller parathyroid glands, and facilitates improved inter-reader agreement.
